Global Disruptive Behavior Disorders (DBD) Market Insights and Forecast to 2031

Report ID: 1451279 | Published Date: Dec 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Stimulants
        1.2.3 Non-stimulants
    1.3 Market by Application
        1.3.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Conduct Disorder (CD)
        1.3.3 Oppositional Defiant Disorder (ODD)
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Disruptive Behavior Disorders (DBD) Market Perspective (2017-2028)
    2.2 Disruptive Behavior Disorders (DBD) Growth Trends by Region
        2.2.1 Disruptive Behavior Disorders (DBD) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Disruptive Behavior Disorders (DBD) Historic Market Size by Region (2017-2022)
        2.2.3 Disruptive Behavior Disorders (DBD) Forecasted Market Size by Region (2023-2028)
    2.3 Disruptive Behavior Disorders (DBD) Market Dynamics
        2.3.1 Disruptive Behavior Disorders (DBD) Industry Trends
        2.3.2 Disruptive Behavior Disorders (DBD) Market Drivers
        2.3.3 Disruptive Behavior Disorders (DBD) Market Challenges
        2.3.4 Disruptive Behavior Disorders (DBD) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue
        3.1.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue (2017-2022)
        3.1.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Players (2017-2022)
    3.2 Global Disruptive Behavior Disorders (DBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Disruptive Behavior Disorders (DBD) Revenue
    3.4 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio
        3.4.1 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Disruptive Behavior Disorders (DBD) Revenue in 2021
    3.5 Disruptive Behavior Disorders (DBD) Key Players Head office and Area Served
    3.6 Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
    3.7 Date of Enter into Disruptive Behavior Disorders (DBD) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Disruptive Behavior Disorders (DBD) Breakdown Data by Type
    4.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Type (2017-2022)
    4.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Type (2023-2028)
5 Disruptive Behavior Disorders (DBD) Breakdown Data by Application
    5.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Application (2017-2022)
    5.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
    6.2 North America Disruptive Behavior Disorders (DBD) Market Size by Type
        6.2.1 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
        6.2.2 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
        6.2.3 North America Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
    6.3 North America Disruptive Behavior Disorders (DBD) Market Size by Application
        6.3.1 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
        6.3.2 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
        6.3.3 North America Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
    6.4 North America Disruptive Behavior Disorders (DBD) Market Size by Country
        6.4.1 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
        6.4.2 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
    7.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Type
        7.2.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
        7.2.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
        7.2.3 Europe Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
    7.3 Europe Disruptive Behavior Disorders (DBD) Market Size by Application
        7.3.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
        7.3.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
        7.3.3 Europe Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
    7.4 Europe Disruptive Behavior Disorders (DBD) Market Size by Country
        7.4.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
        7.4.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
    8.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type
        8.2.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application
        8.3.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region
        8.4.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
    9.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type
        9.2.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
        9.2.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
        9.2.3 Latin America Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
    9.3 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application
        9.3.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
        9.3.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
        9.3.3 Latin America Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
    9.4 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country
        9.4.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
        9.4.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
    10.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type
        10.2.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application
        10.3.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country
        10.4.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Details
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Introduction
        11.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.1.5 Eli Lilly Recent Developments
    11.2 Bionomics
        11.2.1 Bionomics Company Details
        11.2.2 Bionomics Business Overview
        11.2.3 Bionomics Disruptive Behavior Disorders (DBD) Introduction
        11.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.2.5 Bionomics Recent Developments
    11.3 Chelsea Therapeutics
        11.3.1 Chelsea Therapeutics Company Details
        11.3.2 Chelsea Therapeutics Business Overview
        11.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Introduction
        11.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.3.5 Chelsea Therapeutics Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Company Details
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Disruptive Behavior Disorders (DBD) Introduction
        11.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.4.5 Pfizer Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Introduction
        11.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 DURECT
        11.6.1 DURECT Company Details
        11.6.2 DURECT Business Overview
        11.6.3 DURECT Disruptive Behavior Disorders (DBD) Introduction
        11.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.6.5 DURECT Recent Developments
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Disruptive Behavior Disorders (DBD) Introduction
        11.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.7.5 Novartis Recent Developments
    11.8 McNeil Pharmaceuticals
        11.8.1 McNeil Pharmaceuticals Company Details
        11.8.2 McNeil Pharmaceuticals Business Overview
        11.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
        11.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.8.5 McNeil Pharmaceuticals Recent Developments
    11.9 Sunovion Pharmaceuticals
        11.9.1 Sunovion Pharmaceuticals Company Details
        11.9.2 Sunovion Pharmaceuticals Business Overview
        11.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
        11.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.9.5 Sunovion Pharmaceuticals Recent Developments
    11.10 New River Pharmaceuticals
        11.10.1 New River Pharmaceuticals Company Details
        11.10.2 New River Pharmaceuticals Business Overview
        11.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
        11.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
        11.10.5 New River Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Stimulants
    Table 3. Key Players of Non-stimulants
    Table 4. Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Disruptive Behavior Disorders (DBD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Disruptive Behavior Disorders (DBD) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Disruptive Behavior Disorders (DBD) Market Share by Region (2017-2022)
    Table 8. Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Disruptive Behavior Disorders (DBD) Market Share by Region (2023-2028)
    Table 10. Disruptive Behavior Disorders (DBD) Market Trends
    Table 11. Disruptive Behavior Disorders (DBD) Market Drivers
    Table 12. Disruptive Behavior Disorders (DBD) Market Challenges
    Table 13. Disruptive Behavior Disorders (DBD) Market Restraints
    Table 14. Global Disruptive Behavior Disorders (DBD) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Disruptive Behavior Disorders (DBD) Revenue Share by Players (2017-2022)
    Table 16. Global Top Disruptive Behavior Disorders (DBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disruptive Behavior Disorders (DBD) as of 2021)
    Table 17. Ranking of Global Top Disruptive Behavior Disorders (DBD) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Disruptive Behavior Disorders (DBD) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
    Table 21. Date of Enter into Disruptive Behavior Disorders (DBD) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Type (2017-2022)
    Table 25. Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Type (2023-2028)
    Table 27. Global Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Disruptive Behavior Disorders (DBD) Revenue Share by Application (2017-2022)
    Table 29. Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Disruptive Behavior Disorders (DBD) Revenue Share by Application (2023-2028)
    Table 31. North America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Eli Lilly Company Details
    Table 62. Eli Lilly Business Overview
    Table 63. Eli Lilly Disruptive Behavior Disorders (DBD) Product
    Table 64. Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 65. Eli Lilly Recent Developments
    Table 66. Bionomics Company Details
    Table 67. Bionomics Business Overview
    Table 68. Bionomics Disruptive Behavior Disorders (DBD) Product
    Table 69. Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 70. Bionomics Recent Developments
    Table 71. Chelsea Therapeutics Company Details
    Table 72. Chelsea Therapeutics Business Overview
    Table 73. Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Product
    Table 74. Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 75. Chelsea Therapeutics Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Disruptive Behavior Disorders (DBD) Product
    Table 79. Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. Johnson & Johnson Company Details
    Table 82. Johnson & Johnson Business Overview
    Table 83. Johnson & Johnson Disruptive Behavior Disorders (DBD) Product
    Table 84. Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 85. Johnson & Johnson Recent Developments
    Table 86. DURECT Company Details
    Table 87. DURECT Business Overview
    Table 88. DURECT Disruptive Behavior Disorders (DBD) Product
    Table 89. DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 90. DURECT Recent Developments
    Table 91. Novartis Company Details
    Table 92. Novartis Business Overview
    Table 93. Novartis Disruptive Behavior Disorders (DBD) Product
    Table 94. Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 95. Novartis Recent Developments
    Table 96. McNeil Pharmaceuticals Company Details
    Table 97. McNeil Pharmaceuticals Business Overview
    Table 98. McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Product
    Table 99. McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 100. McNeil Pharmaceuticals Recent Developments
    Table 101. Sunovion Pharmaceuticals Company Details
    Table 102. Sunovion Pharmaceuticals Business Overview
    Table 103. Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Product
    Table 104. Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 105. Sunovion Pharmaceuticals Recent Developments
    Table 106. New River Pharmaceuticals Company Details
    Table 107. New River Pharmaceuticals Business Overview
    Table 108. New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Product
    Table 109. New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million)
    Table 110. New River Pharmaceuticals Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Disruptive Behavior Disorders (DBD) Market Share by Type: 2021 VS 2028
    Figure 2. Stimulants Features
    Figure 3. Non-stimulants Features
    Figure 4. Global Disruptive Behavior Disorders (DBD) Market Share by Application: 2021 VS 2028
    Figure 5. Conduct Disorder (CD) Case Studies
    Figure 6. Oppositional Defiant Disorder (ODD) Case Studies
    Figure 7. Disruptive Behavior Disorders (DBD) Report Years Considered
    Figure 8. Global Disruptive Behavior Disorders (DBD) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Disruptive Behavior Disorders (DBD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Disruptive Behavior Disorders (DBD) Market Share by Region: 2021 VS 2028
    Figure 11. Global Disruptive Behavior Disorders (DBD) Market Share by Players in 2021
    Figure 12. Global Top Disruptive Behavior Disorders (DBD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disruptive Behavior Disorders (DBD) as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Disruptive Behavior Disorders (DBD) Revenue in 2021
    Figure 14. North America Disruptive Behavior Disorders (DBD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 15. North America Disruptive Behavior Disorders (DBD) Market Size Market Share by Type (2017-2028)
    Figure 16. North America Disruptive Behavior Disorders (DBD) Market Size Market Share by Application (2017-2028)
    Figure 17. North America Disruptive Behavior Disorders (DBD) Market Size Share by Country (2017-2028)
    Figure 18. United States Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Disruptive Behavior Disorders (DBD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Disruptive Behavior Disorders (DBD) Market Size Market Share by Type (2017-2028)
    Figure 22. Europe Disruptive Behavior Disorders (DBD) Market Size Market Share by Application (2017-2028)
    Figure 23. Europe Disruptive Behavior Disorders (DBD) Market Size Share by Country (2017-2028)
    Figure 24. Germany Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size Market Share by Type (2017-2028)
    Figure 32. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size Market Share by Application (2017-2028)
    Figure 33. Asia Pacific Disruptive Behavior Disorders (DBD) Market Size Share by Region (2017-2028)
    Figure 34. China Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Disruptive Behavior Disorders (DBD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Latin America Disruptive Behavior Disorders (DBD) Market Size Market Share by Type (2017-2028)
    Figure 42. Latin America Disruptive Behavior Disorders (DBD) Market Size Market Share by Application (2017-2028)
    Figure 43. Latin America Disruptive Behavior Disorders (DBD) Market Size Share by Country (2017-2028)
    Figure 44. Mexico Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size Market Share by Type (2017-2028)
    Figure 48. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size Market Share by Application (2017-2028)
    Figure 49. Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size Share by Country (2017-2028)
    Figure 50. Turkey Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. UAE Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Eli Lilly Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 54. Bionomics Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 55. Chelsea Therapeutics Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 58. DURECT Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 60. McNeil Pharmaceuticals Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 61. Sunovion Pharmaceuticals Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 62. New River Pharmaceuticals Revenue Growth Rate in Disruptive Behavior Disorders (DBD) Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals
Frequently Asked Questions
Disruptive Behavior Disorders (DBD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Disruptive Behavior Disorders (DBD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Disruptive Behavior Disorders (DBD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports